Sign in

Stephen John Sammut

@stephensammut.bsky.social
300 followers 295 following 9 posts

Breast cancer physician scientist. Group Leader, ICR London. Consultant oncologist, the Royal Marsden Hospital. Advancing personalised breast cancer medicine through data integration and AI.

PostsRepliesMedia
Reposted by Stephen John Sammut
CRUK Convergence Science Centre @crukconvergence.bsky.social · 12/08/2026
Can AI predict cancer's next move? @stephensammut.bsky.social is using #AI to understand how #BreastCancer changes during treatment, personalising #Cancer care. 👉 buff.ly/P9vBRKq This is the first in our Assistant Director Research Spotlight series. Follow for more from the Centre. @icr.ac.uk
Photo of Stephen with a quote saying "We're trying to use AI to build clinical 'crystal balls', tools that can help predict the right drug, for the right person, at the right time."
032
Reposted by Stephen John Sammut
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 06/02/2026
www.nature.com/articles/s41... Once more #METABRIC continues to enable major discoveries! @urialonlab.bsky.social used our data to do this 👇
nature.com
Temporal tissue dynamics from a spatial snapshot - Nature
One-shot tissue dynamics reconstruction can infer changes in tissue composition over time, from single-time-point spatial proteomics of human cancers.
122
Reposted by Stephen John Sammut
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 16/01/2026
One of the greatest privileges of my career has been to mentor amazing researchers that now run their own labs. Four of them just sent me this picture: @hrazaalilab.bsky.social @ruedalab.bsky.social @stephensammut.bsky.social and Alex Bruna @icr.ac.uk
0115
Reposted by Stephen John Sammut
The Lister Institute of Preventive Medicine @thelisterinstitute.bsky.social · 09/12/2025
Triple-negative breast cancer in biomed news this week🏥 So perfect timing to feature #ListerFellow @stephensammut.bsky.social 🤩He's hunting clinical biomarkers and using AI to predict treatment response from immune activation. Repost and read ⤵️ lister-institute.org.uk/in-conversat... @icr.ac.uk
032
Reposted by Stephen John Sammut
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 10/11/2025
Fantastic work by @kevinjtu.bsky.social done as MSc @caldaslab.bsky.social in collaboration with @ruedalab.bsky.social and @stephensammut.bsky.social. #TME deconvolution in 15,000 breast cancers! #METABRIC @ims-mrl.bsky.social @hebrewuniversity.bsky.social @lautenbergc.bsky.social 🥳🥳👍👍💪💪
143
Reposted by Stephen John Sammut
Kevin Tu @kevinjtu.bsky.social · 10/11/2025
My poor laptop wishes I learned how to use the cluster earlier, but it’s sacrifice was not in vain! We learned some important things about the breast cancer tumor microenvironment, described in our paper published today: www.cell.com/cell-reports... Here's the 🧵
1145
Reposted by Stephen John Sammut
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 14/07/2025
The first report of ML to integrate multi-omic data to generate a therapy response predictor. In a little over 3 years now cited >300 times in Web of Science! Incredibly proud @caldaslab.bsky.social and @stephensammut.bsky.social!! www.nature.com/articles/s41...
nature.com
Multi-omic machine learning predictor of breast cancer therapy response - Nature
Integration of pre-treatment tumour features in predictive models using machine learning could inform on response to therapy.
054
Reposted by Stephen John Sammut
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 12/07/2025
Nice to have our paper highlighted! @caldaslab.bsky.social always walking the walk! www.uhnresearch.ca/news/rare-ca...
uhnresearch.ca
Rare Cancer Cells Fuel Tumours
Scientists uncover how a small number of cancer cells can drive tumour growth in breast cancer.
053
Stephen John Sammut @stephensammut.bsky.social · 19/06/2025
Incredibly humbled and honoured to have been awarded the 2025 Research Prize from @thelisterinstitute.bsky.social. ❤️ 🧬 We’re harnessing high-resolution molecular profiling + AI to uncover how cancer disables the immune system and find ways of restoring it. @icr.ac.uk #bcsm #ai #CancerResearch
5173
Reposted by Stephen John Sammut
The Institute of Cancer Research @icr.ac.uk · 19/06/2025
Our warmest congratulations to Dr Stephen John Sammut, who has been awarded a highly prestigious research prize from @thelisterinstitute.bsky.social 🎉🏆 These awards aim to make a significant difference to the research work of scientists in the early years of running their own groups.
1155
Reposted by Stephen John Sammut
The Institute of Cancer Research @icr.ac.uk · 05/06/2025
Huge congratulations to Dr Stephen-John Sammut from the Breast Cancer Now Toby Robins Research Centre at the ICR, who's been awarded the BACR/AstraZeneca Young Scientist Frank Rose Award for 2024! 👏 @astra-zeneca.bsky.social @breastcancernow.bsky.social @stephensammut.bsky.social #BACR2025 #BACR25
Dr Stephen-John Sammut pictured in his lab with a lab coat on.
2143
Stephen John Sammut @stephensammut.bsky.social · 12/05/2025
Lentiviral barcoding used to track the clonal growth of over 20,000 single-cell-derived clones in 110 xenografts from 26 patient-derived breast cancer xenograft models. Beautiful work @nguyenlab.bsky.social!!
172
Reposted by Stephen John Sammut
Cold Spring Harbor Laboratory @cshlnews.bsky.social · 29/04/2025
A new Science summary spotlights a paper by CSHL’s Tobias Janowitz and colleagues that uncovers a neural circuit linking inflammation to reduced motivation in a mouse model of cancer cachexia. Check out the Science summary here: www.science.org/doi/10.1126/... #Cachexia #ScienceMagazine
science.org
How does cancer affect motivation?
Inflammatory cytokines hijack a brain circuit to cause apathy in cancer
094
Reposted by Stephen John Sammut
Elizabeth McKenna @elizsmckenna.bsky.social · 27/04/2025
Online now in Cancer Discovery concurrent with the #AACR25 Opening Plenary, by plenary speaker Paul Mischel: A Guide to Extrachromosomal DNA (#ecDNA): Cancer's Dynamic Circular Genome doi.org/10.1158/2159...
0133
Reposted by Stephen John Sammut
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 27/04/2025
ecDNA @theaacr.bsky.social Paul Mischel from Stanford. In breast cancer ecDNA is the main mechanism of amplification of the ER+ oncogene we co-discovered ZNF703! @caldaslab.bsky.social
064
Reposted by Stephen John Sammut
Trevor Graham @trevorgraham.bsky.social · 23/04/2025
dATAC: our new method for simultaneous very high quality whole genome sequencing and chromatin accessibility profiling of single cells. We used dATAC to trace epigenome clonal evolution in colon cancer. Devised by the extraordinarily talented @maxmossner.bsky.social www.biorxiv.org/content/10.1...
biorxiv.org
Single cell multi-omic whole genome sequencing and chromatin accessibility profiling reveals genome-epigenome coevolution in colorectal cancer
Epigenetic alterations co-evolve with genetic mutations to drive carcinogenesis and treatment response. Resolving genome-epigenome coevolution requires accurate multi-omic single cell measurement. Her...
1307
Stephen John Sammut @stephensammut.bsky.social · 22/04/2025
Amazing work @ruedalab.bsky.social !!
031
Reposted by Stephen John Sammut
Oscar M Rueda @ruedalab.bsky.social · 16/04/2025
Excited to share our latest work on monitoring response to treatment using ctDNA and shallow WGS using a Bayesian Model developed by Solon Karapanagiotis with @Carloscaldas1960.bsky.social, Emma Beddowes and @mortegaduran.bsky.social febs.onlinelibrary.wiley.com/doi/full/10....
0128
Reposted by Stephen John Sammut
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 16/04/2025
1/n Fantastic to see this published. Anticipatory genomics demonstration: ctDNA and ML to predict CT progression! Well done @emmajb001.bsky.social and @mortegaduran.bsky.social! Great collaboration of @caldaslab.bsky.social with @ruedalab.bsky.social! #DETECT started by @sj-dawson.bsky.social!
165
Stephen John Sammut @stephensammut.bsky.social · 21/03/2025
Join Our Team! We're looking for a #computational #postdoc to join our group @icr.ac.uk in Chelsea #hiring We are using single-cell methods to model breast tumour evolution during chemo + immuno-therapy, using serial tumour samples More details: jobs.icr.ac.uk/vacancies/11... #bcsm
jobs.icr.ac.uk
Postdoctoral Training Fellow - Computational Single Cell Biology (Dr Stephen-John Sammut) in Chelsea | The Institute of Cancer Research
View details and apply for this Postdoctoral Training Fellow - Computational Single Cell Biology (Dr Stephen-John Sammut) vacancy in Chelsea . Salary: Starting salary is based on previ...
093
Reposted by Stephen John Sammut
Nature Portfolio @natureportfolio.nature.com · 05/03/2025
Aspirin may enhance the immune response against cancer metastasis in mice, according to research published in Nature. The authors suggest that the findings could aid the development of effective anti-metastatic immunotherapies. go.nature.com/3F3GWOB 🧪
This is figure 5, which shows that aspirin promotes anti-metastatic immunity by releasing T cells from ARHGEF1-dependent suppression by TXA2.
25014
Reposted by Stephen John Sammut
Maurizio Callari @mauriziocallari.bsky.social · 05/03/2025
📢 Our work just published in @naturecomms.bsky.social @natureportfolio.nature.com! What is driving #response to #targeted #treatments in HER2+ER+ #breastcancer? How is the tumour ecosystem affected by treatment? Find the answers in our paper 👉 rdcu.be/ecbVR Key points below 👇
rdcu.be
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies
Nature Communications - NA-PHER2 was a neoadjuvant trial of HER2-targeted trastuzumab and pertuzumab plus the CDK4/6 inhibitor palbociclib with or without endocrine therapy in HER2-positive,...
2165
Reposted by Stephen John Sammut
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 15/02/2025
In ILC, after neo-adjuvant therapy, RCB retains prognostic value. @caldaslab.bsky.social and @stephensammut.bsky.social happy to have contributed. Walking the walk. www.nature.com/articles/s41...
nature.com
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer - npj Breast Cancer
npj Breast Cancer - A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer
096
Reposted by Stephen John Sammut
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 05/02/2025
@caldaslab.bsky.social proud to contribute to this! ML/AI to quantify CD31 IHC of blood vessels in breast cancer! Well done lead author Tristan Whitmarsh! pubmed.ncbi.nlm.nih.gov/39905431/
pubmed.ncbi.nlm.nih.gov
Quantifying the tumour vasculature environment from CD-31 immunohistochemistry images of breast cancer using deep learning based semantic segmentation - PubMed
Our proposed method shows promise as a tool for studying the tumour vasculature and its relationship with surrounding cells and tissue types. Furthermore, the correlation with tumour grade highlights ...
143
Reposted by Stephen John Sammut
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 06/02/2025
Important translational piece from @icrlondon.bsky.social and Brisken lab. Yet again #METABRIC being used to develop/validate tool! @caldaslab.bsky.social research continues to have huge impact! Walking the walk! www.icr.ac.uk/about-us/icr...
icr.ac.uk
New data tool could bring RNA sequencing into standard clinical practice, improving diagnosis and treatment
New data tool could bring RNA sequencing into standard clinical practice, improving diagnosis and treatment
043
Reposted by Stephen John Sammut
Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧 @carloscaldas1960.bsky.social · 23/01/2025
We published this exactly 3 years ago. Already Highly Cited (250 citations on WoS!!). Thanks to @stephensammut.bsky.social @ercresearch.bsky.social @cruk-ci.bsky.social @caldaslab.bsky.social Pioneered use of ML/AI for multi-omic data integration. Walking the walk! www.nature.com/articles/s41...
nature.com
Multi-omic machine learning predictor of breast cancer therapy response - Nature
Integration of pre-treatment tumour features in predictive models using machine learning could inform on response to therapy.
083